New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export HR’s income statement to Excel — free account
Healthcare Realty Trust Incorporated
HRReal Estate Reit Healthcare Facilities
Healthcare Realty Trust Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, down 6.92% from fiscal 2024.
- Revenue
- −3.74%
- EPS
- n/m
- Free cash flow
- −65.2%
- Total debt
- +2.51%
Quarter to September 2026, against a year earlier
19.38
0.02
+0.10%
After hours trading: 19.36, down 0.10%, last trade 4:01pm Eastern.
Follow HR
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 2.19% in Q3 FY26, the highest of these four quarters.
ROEROIC
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | −4.9% | −4.2% | −1.9% | −1.0% |
| ROIC | 1.2% | 1.5% | 1.9% | 2.2% |
Debt
Net debt is 0.33× a year’s EBITDA. Debt is 0.02× equity.
Debt / equityNet debt / EBITDA
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Debt / equity | 0.0× | 0.0× | 0.0× | 0.0× |
| Net debt / EBITDA | 0.3× | 0.3× | 0.3× | 0.3× |
Per share, from Q4 FY25
Since Q4 FY25, per share: free cash flow has fallen 20.7%; revenue has fallen 1.37%; book value has fallen 9.23%.
Free cash flowRevenueBook value
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Free cash flow | 1.0× | 1.0× | 1.0× | 0.8× |
| Revenue | 1.0× | 1.0× | 1.0× | 1.0× |
| Book value | 1.0× | 1.0× | 0.9× | 0.9× |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(4.93%) | (4.18%) | (1.90%) | (1.01%) | |
Piotroski F-Score |
5 | 6 | 5 | 5 | |
| (2.48%) | (2.05%) | (0.90%) | (0.48%) | ||
ROIC |
1.23% | 1.46% | 1.87% | 2.19% | |
Return on Tangible Assets |
(6.48%) | (5.58%) | (2.53%) | (1.40%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
4.18 | 4.24 | 4.13 | 3.31 | |
Free Cash Flow |
1,461.62 | 1,474.56 | 1,413.01 | 1,128.08 | |
Capital Expenditures |
1,004.52 | 1,012.37 | 971.86 | 678.39 | |
| Other line items | |||||
Cash ROIC |
30.62% | 32.10% | 32.39% | 26.71% | |
Accounts Payable Turnover |
2.07 | 3.11 | 2.45 | 2.45 | |
Average Days of Payables |
171.55 | 114.44 | 134.33 | 150.35 | |
Selling, General and Administrative Expense of Revenue |
6.15% | 6.58% | 5.87% | 5.11% | |
Share Based Compensation of Revenue |
1.90% | 2.14% | 1.78% | 1.57% | |
Interest Coverage |
0.44 | 0.54 | 0.68 | 0.81 | |
Operating CF/Net income |
(1.86) | (2.30) | (5.08) | (10.01) | |
Depreciation/Fixed assets |
0.07 | 0.07 | 0.07 | 0.07 | |
Capex/Depreciation |
1.71 | 1.79 | 1.80 | 1.29 | |
Revenue per Share |
3.37 | 3.34 | 3.34 | 3.33 | |
Operating CF per Share |
1.31 | 1.33 | 1.29 | 1.32 | |
Capex per Share |
2.87 | 2.91 | 2.84 | 1.99 | |
Capex to Sales |
(0.85) | (0.87) | (0.85) | (0.60) |
Columns are period end dates · fundamentals updated Nov 18, 2026